# A Prospective Randomized Controlled Study of Radiotherapy and the Concurrent Three-week and Single-week TP Chemotherapy for Advanced Cervical Squamous Cell Carcinoma and the Correlation Between HPV Classification and Sensitivity.

> **NCT04588090** · NA · UNKNOWN · sponsor: **Chongqing University Cancer Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Cervical Cancer

## Interventions

- **PROCEDURE:** The concurrent 3 weeks TP regimen
- **PROCEDURE:** The concurrent weekly TP regimen
- **RADIATION:** External radiation plus intraluminal after-loading irradiation

## Key facts

- **NCT ID:** NCT04588090
- **Lead sponsor:** Chongqing University Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-01-01
- **Primary completion:** 2021-01-01
- **Final completion:** 2021-05-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2020-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04588090

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04588090, "A Prospective Randomized Controlled Study of Radiotherapy and the Concurrent Three-week and Single-week TP Chemotherapy for Advanced Cervical Squamous Cell Carcinoma and the Correlation Between HPV Classification and Sensitivity.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04588090. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*